USP53 and hepatocellular carcinoma: Furthermore, orthotopic tumors derived from the USP53-overexpressing HCC cells showed weaker PET-CT signals compared to control group, which were derived from the same HCCLM3 cells without USP53 overexpression (Fig. 3D, E).